Concert Genetics
Shelby Powell has a diverse work experience spanning various industries. Shelby started as a Summer Intern at MORC, Inc in 2016 and continued in that role until 2017. From 2018 to 2020, they worked as a Restaurant Server at ROCKWELL REPUBLIC. In 2020, they interned as a Clinical Intern at Progenity, Inc. Following this, they were a Biopharma Technician at Aegis Sciences Corporation from 2021 to 2022. Currently, Shelby works at Concert Genetics as a Genetic Counseling Assistant/Clinical Data Curator, starting in January 2022.
Shelby Powell attended Ferris State University from 2016 to 2020, where they earned a Bachelor of Science degree in Molecular Diagnostics.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.